These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17319250)

  • 21. Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.
    Stallvik M; Nordstrand B; Kristensen Ø; Bathen J; Skogvoll E; Spigset O
    Drug Alcohol Depend; 2013 Apr; 129(1-2):88-93. PubMed ID: 23084592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. QTc interval prolongation associated with intravenous methadone.
    Kornick CA; Kilborn MJ; Santiago-Palma J; Schulman G; Thaler HT; Keefe DL; Katchman AN; Pezzullo JC; Ebert SN; Woosley RL; Payne R; Manfredi PL
    Pain; 2003 Oct; 105(3):499-506. PubMed ID: 14527710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of opioid receptor agonist and antagonist medications on electrocardiogram changes and presentation of cardiac arrhythmia: review article.
    Etaee F; Tobin M; Vuppala S; Komaki A; Delisle BP; Di Biase L; Catanzaro JN; Natale A; Elayi CS
    J Interv Card Electrophysiol; 2022 Mar; 63(2):471-500. PubMed ID: 34674120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QT interval prolongation in opioid agonist treatment: analysis of continuous 12-lead electrocardiogram recordings.
    Isbister GK; Brown AL; Gill A; Scott AJ; Calver L; Dunlop AJ
    Br J Clin Pharmacol; 2017 Oct; 83(10):2274-2282. PubMed ID: 28488266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QTc prolongation: methadone's efficacy-safety paradox.
    Krantz MJ; Mehler PS
    Lancet; 2006 Aug; 368(9535):556-7. PubMed ID: 16905001
    [No Abstract]   [Full Text] [Related]  

  • 26. Methadone Therapy in Underserved Urban Community: QTc Prolongation and Life-Threatening Ventricular Arrhythmias.
    Chowdhury M; Wong J; Cheng A; Khilkin M; Palma E
    Cardiovasc Ther; 2015 Jun; 33(3):127-33. PubMed ID: 25825202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen.
    Fanoe S; Hvidt C; Ege P; Jensen GB
    Heart; 2007 Sep; 93(9):1051-5. PubMed ID: 17344330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The successful use of parenteral methadone in a patient with a prolonged QTc interval.
    Sekine R; Obbens EA; Coyle N; Inturrisi CE
    J Pain Symptom Manage; 2007 Nov; 34(5):566-9. PubMed ID: 17616330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing cardiac safety among clients receiving methadone as part of opioid agonist maintenance therapy (OAMT) in Durban, South Africa.
    Prakaschandra DR; Scheibe A; Marks M; Naidoo DP
    J Addict Dis; 2023; 41(1):82-90. PubMed ID: 35437125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence of QT prolongation in a population of patients with substance use disorders.
    Scott AJ; Dunlop AJ; Brown A; Sadler C; Isbister GK
    Drug Alcohol Rev; 2017 Mar; 36(2):239-244. PubMed ID: 27241860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attitudes, Beliefs, and Practices of Pediatric Palliative Care Physicians Regarding the Use of Methadone in Children With Advanced Cancer.
    Madden K; Liu D; Bruera E
    J Pain Symptom Manage; 2019 Feb; 57(2):260-265. PubMed ID: 30447383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged QT interval by methadone: relevance for daily practice? A prospective study in patients with cancer and noncancer pain.
    van den Beuken-van Everdingen MH; Geurts JW; Patijn J
    J Opioid Manag; 2013; 9(4):263-7. PubMed ID: 24353019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective study of QTc changes among former opiate addicts since admission to methadone maintenance treatment: benzodiazepine risk.
    Peles E; Linzy S; Kreek MJ; Adelson M
    J Addict Med; 2013; 7(6):428-34. PubMed ID: 24145160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corrected QT Interval Prolongation in Hospitalized Pediatric Patients Receiving Methadone.
    Schwinghammer AJ; Wilson MD; Hall BA
    Pediatr Crit Care Med; 2018 Aug; 19(8):e403-e408. PubMed ID: 29894447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid maintenance patients with QTc prolongation: congenital long QT syndrome mutation may be a contributing risk factor.
    Anchersen K; Hansteen V; Gossop M; Clausen T; Waal H
    Drug Alcohol Depend; 2010 Dec; 112(3):216-9. PubMed ID: 20702049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of long QTc interval in methadone maintenance patients.
    Fonseca F; Marti-Almor J; Pastor A; Cladellas M; Farré M; de la Torre R; Torrens M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):327-32. PubMed ID: 18774239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methadone-induced Torsade de pointes tachycardias.
    Sticherling C; Schaer BA; Ammann P; Maeder M; Osswald S
    Swiss Med Wkly; 2005 May; 135(19-20):282-5. PubMed ID: 15986265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes of QTc interval after opioid switching to oral methadone.
    Mercadante S; Prestia G; Adile C; Casuccio A
    Support Care Cancer; 2013 Dec; 21(12):3421-4. PubMed ID: 23949740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
    Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
    Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QTc prolongation and torsades de pointes associated with methadone therapy.
    Routhier DD; Katz KD; Brooks DE
    J Emerg Med; 2007 Apr; 32(3):275-8. PubMed ID: 17394991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.